HGF Partner Craig Thomson will be speaking at the 4th Microbiome: Recent Developments, Regulatory, Quality and Commercialization Summit on 15th October.
The Summit will shed light on current challenges, best practices, and inside views of the future of microbiome-based products in relation to the quality, safety, and efficiency.
The speakers will discuss key findings, critical insights, and recommendations for driving efficient strategies within the microbiome landscape.
HGF Partner Craig Thomson will be presenting on Thursday 15th October:
Microbiome and IP – How to Build a Commercially Relevant Patent Portfolio
For any Microbiome Innovator, there are many combinations of reasons to consider building an IP Portfolio: to protect a monopoly of sales for your product or service, to enhance valuation of your company for sale, to enhance your bargaining position with a collaborator or competitor, or to form part of the package designed to attract investors. No matter the reason, or combinations of reasons, a coherent IP strategy that recognises the specific timelines and commercial goals of your company is vital. Using the International IP systems to protect many of the innovations in the microbiome field has very specific challenges; adding another burden to the job of creating of an appropriate IP strategy. Indeed, an important part of such a strategy is the consideration of when not to protect by registered IP rights. Craig will provide a road-map of actions to be taken and considered when developing such strategies for a Microbiome innovator.
Click here to find out more about the event.